Loading insider details...
Beta
Latest Form 4 (Jul 23, 2026): Grant/Award of 30,500 SER shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 23, 2026 | Serina Therapeutics, Inc. (SER) | Grant/Award | 30,500 | n/a |
| Feb 20, 2026 | Trevi Therapeutics, Inc. (TRVI) | Grant/Award | 160,000 | n/a |
| Jun 3, 2025 | Trevi Therapeutics, Inc. (TRVI) | Grant/Award | 72,000 | n/a |
| Mar 12, 2025 | Trevi Therapeutics, Inc. (TRVI) | Exercise/Conversion | 17,500 | $56.2K |
| Feb 20, 2025 | Trevi Therapeutics, Inc. (TRVI) | Grant/Award | 225,500 | n/a |
| Feb 16, 2024 | Trevi Therapeutics, Inc. (TRVI) | Grant/Award | 175,000 | n/a |
| Jun 21, 2023 | Trevi Therapeutics, Inc. (TRVI) | Exercise/Conversion | 6,250 | $3.2K |
| Mar 8, 2023 | Trevi Therapeutics, Inc. (TRVI) | Exercise/Conversion | 18,750 | $9.6K |
| Feb 16, 2023 | Trevi Therapeutics, Inc. (TRVI) | Grant/Award | 100,000 | n/a |